Autoimmune Hemolytic Anemia

Autoimmune hemolytic anemia (AIHA) is a rare condition where your body's immune system mistakenly attacks and destroys its own red blood cells. These cells carry oxygen throughout your body. When too many red blood cells are destroyed too quickly, it leads to anemia, causing symptoms like fatigue and shortness of breath.

What is Autoimmune Hemolytic Anemia?

Autoimmune hemolytic anemia (AIHA) is a group of rare blood disorders where your immune system, which normally fights off germs, mistakenly attacks and destroys your own red blood cells. This destruction happens faster than your body can make new ones, leading to a shortage of red blood cells (anemia) and affecting how oxygen is carried throughout your body.

Your red blood cells are vital for carrying oxygen from your lungs to all parts of your body. In AIHA, your immune system produces proteins called autoantibodies. These autoantibodies attach to your red blood cells, marking them for destruction. This process is called hemolysis. There are different types of AIHA, primarily categorized by the temperature at which the autoantibodies are most active. Warm AIHA is the most common type, where autoantibodies react with red blood cells at normal body temperature. Cold agglutinin disease (CAD), a type of cold AIHA, involves autoantibodies that are active at colder temperatures, often below normal body temperature. AIHA can be acute, meaning it comes on suddenly and severely, or chronic, meaning it develops slowly and lasts for a long time. The severity of the condition can vary greatly from person to person, ranging from mild to life-threatening. Early diagnosis and treatment are important to manage symptoms and prevent complications.

Symptoms

Symptoms of autoimmune hemolytic anemia (AIHA) result from a shortage of red blood cells and reduced oxygen delivery to your body's tissues. Common signs include feeling very tired (fatigue), weakness, dizziness, and shortness of breath, especially with activity. Your skin might also look paler than usual.

The symptoms of AIHA can develop gradually or appear suddenly, depending on how quickly red blood cells are being destroyed. Because red blood cells carry oxygen, a rapid decrease can lead to more severe symptoms. Many symptoms are similar to other types of anemia. Other common symptoms can include a rapid heartbeat (tachycardia), headaches, and feeling lightheaded. Some people may also experience yellowing of the skin or eyes (jaundice) due to the breakdown of red blood cells, which releases a substance called bilirubin. Dark urine can also occur for the same reason. In some cases, an enlarged spleen (splenomegaly) may develop. The spleen is an organ that filters blood and removes old or damaged cells, and it can become overworked when destroying many red blood cells. Less common symptoms might include abdominal discomfort or pain.

Causes & risk factors

Autoimmune hemolytic anemia (AIHA) occurs when your immune system mistakenly attacks your red blood cells. Often, the exact reason for this immune system malfunction is unknown, which is called primary or idiopathic AIHA. In other cases, it's linked to an underlying medical condition or certain medications.

When the cause of AIHA cannot be identified, it is called primary AIHA. This means the immune system begins to attack red blood cells without a clear trigger. This is often the case for many individuals diagnosed with the condition. Secondary AIHA occurs when the condition is caused by or associated with another disease or factor. This can include other autoimmune diseases, such as lupus or rheumatoid arthritis, where the immune system is already overactive. Certain types of cancers, particularly lymphomas and leukemias, can also be associated with AIHA. Infections, such as viral infections like mononucleosis or bacterial infections, can sometimes trigger AIHA. Additionally, some medications, including certain antibiotics (like penicillin) or drugs used to treat high blood pressure, can rarely cause AIHA as a side effect. Your doctor will review your medical history and medications to help determine potential causes or triggers.

How it's diagnosed

Diagnosing autoimmune hemolytic anemia (AIHA) involves a physical exam, reviewing your symptoms, and several blood tests. These tests help confirm anemia, identify red blood cell destruction, and detect the autoantibodies responsible for the attack. A key test is the Coombs test, which looks for antibodies attached to your red blood cells.

Your doctor will start by asking about your medical history and symptoms. During a physical exam, they may look for signs like pale skin, jaundice, or an enlarged spleen. Blood tests are crucial for confirming AIHA and determining its type and severity. A complete blood count (CBC) will show if you have anemia by measuring the number of red blood cells and the amount of hemoglobin. Other blood tests, such as those measuring bilirubin and lactate dehydrogenase (LDH), can indicate that red blood cells are being destroyed. A reticulocyte count measures how quickly your bone marrow is making new red blood cells. The direct antiglobulin test (DAT), also known as the direct Coombs test, is the most important test for diagnosing AIHA. This test detects antibodies attached to the surface of your red blood cells. An indirect Coombs test may also be performed to find antibodies in the liquid part of your blood (serum). Further tests might be done to identify any underlying conditions that could be causing secondary AIHA.

Treatment options

Treatment for autoimmune hemolytic anemia (AIHA) aims to stop the immune system from destroying red blood cells, increase red blood cell counts, and manage symptoms. The initial treatment often involves corticosteroids to suppress the immune system. Other options include medications that modify the immune response, removal of the spleen, or blood transfusions.

Corticosteroids, such as prednisone, are usually the first line of treatment. These medications work by reducing the activity of your immune system, thereby decreasing the destruction of red blood cells. The dose is typically high at first and then gradually reduced as your condition improves. If corticosteroids are not effective or if you cannot tolerate them, other treatments may be considered. These include other immunosuppressive drugs, such as rituximab, azathioprine, or cyclosporine, which further calm the immune system. Intravenous immunoglobulin (IVIG) can also be used to temporarily block the autoantibodies. For some people, surgical removal of the spleen (splenectomy) may be an option, especially in warm AIHA that doesn't respond to medication. The spleen is a major site where antibody-coated red blood cells are destroyed. Blood transfusions may be given to quickly increase red blood cell counts in severe cases, but they are often a temporary measure while other treatments take effect. Treating any underlying condition causing secondary AIHA is also a critical part of the overall treatment plan.

Recovery & outlook

The recovery and outlook for autoimmune hemolytic anemia (AIHA) vary widely depending on the type, severity, and response to treatment. Many people respond well to initial treatments like corticosteroids, but some may require ongoing therapy or experience relapses. Regular monitoring by a doctor is essential to manage the condition effectively.

For many individuals with AIHA, especially those with primary warm AIHA, treatment with corticosteroids can lead to remission, meaning the symptoms improve and red blood cell counts return to normal. However, some people may experience a relapse when corticosteroids are tapered or stopped, requiring further treatment. If AIHA is secondary to another condition, successfully treating the underlying disease can often lead to improvement or resolution of the anemia. For those who do not respond to initial treatments, or who have chronic AIHA, long-term management with other immunosuppressants or splenectomy may be necessary. While AIHA can be a serious condition, advancements in treatment have significantly improved the outlook for most people. Regular follow-up appointments with your healthcare provider are crucial to monitor your blood counts, adjust medications, and watch for any signs of relapse or complications. Your doctor will work with you to create a personalized treatment and monitoring plan.

When to see a doctor

You should see a doctor if you experience new or worsening symptoms of anemia, such as extreme fatigue, shortness of breath, dizziness, or pale skin. Seek immediate medical attention if you have severe symptoms like fainting, chest pain, or very rapid breathing, as these could indicate a medical emergency.

If you notice any persistent symptoms that suggest anemia, such as unusual tiredness, weakness, or feeling short of breath with minimal exertion, it's important to schedule an appointment with your doctor. These symptoms could be signs of AIHA or another underlying health issue that requires diagnosis and treatment. For those already diagnosed with AIHA, it's crucial to contact your doctor if your symptoms worsen, if you develop new symptoms, or if you experience side effects from your medications. Your treatment plan may need to be adjusted. Seek emergency medical care immediately if you experience severe symptoms such as sudden, profound weakness or dizziness, fainting spells, severe chest pain, or difficulty breathing. These could be signs of a critical drop in red blood cell count requiring urgent intervention, such as a blood transfusion.

Frequently asked questions

Is autoimmune hemolytic anemia a serious condition?

Yes, autoimmune hemolytic anemia (AIHA) can be a serious condition. It can range from mild to life-threatening, depending on how quickly red blood cells are destroyed and how severe the anemia becomes. Prompt diagnosis and treatment are important to manage symptoms and prevent complications.

Can AIHA be cured?

AIHA can often go into remission with treatment, meaning symptoms improve and blood counts normalize. For some, especially those with primary AIHA, this remission can be long-lasting. However, some people may experience relapses or require ongoing treatment to manage the condition, particularly if it's secondary to another disease.

What is the difference between warm and cold AIHA?

The difference lies in the temperature at which the autoantibodies are most active. In warm AIHA, the most common type, antibodies react with red blood cells at normal body temperature. In cold AIHA (like cold agglutinin disease), antibodies are active at colder temperatures, often below normal body temperature.

Are there any dietary restrictions for AIHA?

The sources provided do not specify particular dietary restrictions for AIHA. However, a balanced diet is generally recommended for overall health. Your doctor may advise on specific nutritional needs, especially if you have other underlying conditions or if certain treatments affect your appetite or nutrient absorption.

Can AIHA affect pregnancy?

The provided sources do not specifically detail the effects of AIHA on pregnancy. If you have AIHA and are pregnant or planning to become pregnant, it is essential to discuss this with your doctor. They can provide personalized advice and monitor your condition closely to ensure the best outcomes for both you and your baby.

How often do I need follow-up appointments after AIHA diagnosis?

Regular follow-up appointments are crucial for managing AIHA. The frequency will depend on the severity of your condition, your response to treatment, and whether you are in remission. Your doctor will monitor your blood counts and overall health, adjusting your treatment plan as needed. Always follow your doctor's specific recommendations.

Sources

• MedlinePlus — Autoimmune Hemolytic Anemia
• Mayo Clinic — Autoimmune Hemolytic Anemia
• Cochrane Library — Autoimmune Hemolytic Anemia